Integral Ad Science Holding Corp. (NASDAQ:IAS) Receives Consensus Rating of “Moderate Buy” from Analysts

Shares of Integral Ad Science Holding Corp. (NASDAQ:IAS) have earned an average rating of “Moderate Buy” from the twelve brokerages that are currently covering the firm, Marketbeat.com reports. Three research analysts have rated the stock with a hold rating and nine have issued a buy rating on the company. The average 1-year price objective among brokerages that have updated their coverage on the stock in the last year is $17.58.

A number of equities analysts recently commented on the stock. Barclays decreased their price objective on shares of Integral Ad Science from $16.00 to $12.00 and set an “equal weight” rating for the company in a research note on Monday, April 15th. Truist Financial decreased their price objective on shares of Integral Ad Science from $26.00 to $17.00 and set a “buy” rating for the company in a report on Wednesday, February 28th. Bank of America assumed coverage on shares of Integral Ad Science in a research report on Thursday, January 11th. They set a “buy” rating and a $19.00 target price for the company. Morgan Stanley reaffirmed an “equal weight” rating and set a $12.00 price objective (down previously from $18.00) on shares of Integral Ad Science in a research report on Tuesday, April 16th. Finally, Piper Sandler cut their price objective on shares of Integral Ad Science from $20.00 to $18.00 and set an “overweight” rating for the company in a research report on Wednesday, February 28th.

Insiders Place Their Bets

In other news, CAO Alexis Gil II sold 3,177 shares of the stock in a transaction that occurred on Monday, March 4th. The shares were sold at an average price of $10.24, for a total transaction of $32,532.48. Following the sale, the chief accounting officer now directly owns 120,195 shares of the company’s stock, valued at $1,230,796.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other Integral Ad Science news, CAO Alexis Gil II sold 3,177 shares of the firm’s stock in a transaction that occurred on Monday, March 4th. The shares were sold at an average price of $10.24, for a total value of $32,532.48. Following the transaction, the chief accounting officer now directly owns 120,195 shares of the company’s stock, valued at $1,230,796.80. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO Lisa Utzschneider sold 13,113 shares of the firm’s stock in a transaction that occurred on Tuesday, February 6th. The shares were sold at an average price of $15.79, for a total transaction of $207,054.27. Following the completion of the transaction, the chief executive officer now directly owns 148,657 shares in the company, valued at $2,347,294.03. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 80,195 shares of company stock valued at $876,562. 2.00% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Integral Ad Science

Hedge funds and other institutional investors have recently bought and sold shares of the business. Skandinaviska Enskilda Banken AB publ acquired a new stake in Integral Ad Science in the third quarter worth $58,000. DekaBank Deutsche Girozentrale acquired a new stake in shares of Integral Ad Science during the third quarter worth $62,000. Amalgamated Bank raised its holdings in shares of Integral Ad Science by 19.9% during the third quarter. Amalgamated Bank now owns 6,951 shares of the company’s stock worth $83,000 after acquiring an additional 1,156 shares during the period. Sherbrooke Park Advisers LLC acquired a new stake in shares of Integral Ad Science during the third quarter worth $140,000. Finally, L2 Asset Management LLC acquired a new stake in shares of Integral Ad Science during the third quarter worth $142,000. 95.78% of the stock is owned by institutional investors.

Integral Ad Science Price Performance

NASDAQ IAS opened at $9.57 on Wednesday. Integral Ad Science has a 12 month low of $8.92 and a 12 month high of $20.88. The company has a debt-to-equity ratio of 0.17, a current ratio of 3.21 and a quick ratio of 3.21. The firm has a market capitalization of $1.53 billion, a PE ratio of 239.31, a P/E/G ratio of 1.58 and a beta of 1.60. The company’s 50 day simple moving average is $11.02 and its 200 day simple moving average is $13.00.

Integral Ad Science (NASDAQ:IAS) last posted its quarterly earnings results on Tuesday, February 27th. The company reported $0.06 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.03 by $0.03. The firm had revenue of $134.30 million for the quarter, compared to analyst estimates of $131.27 million. Integral Ad Science had a net margin of 1.53% and a return on equity of 0.83%. The firm’s quarterly revenue was up 14.4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.07 earnings per share. As a group, equities research analysts forecast that Integral Ad Science will post 0.16 EPS for the current fiscal year.

About Integral Ad Science

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.